Diabetes Update: Moving Ahead of the Curve
Presented by Dave Joffe, RPh, CDE, CPT, FACA
Editor of DiabetesinControl.com
Program Overview:
Pharmacists are often the medical professional that patients reach out to for the latest in drug and device information. With all the new products available for diabetes it is very difficult for the Pharmacist to keep up with the latest advances in medication and devices for Diabetes Care. In addition, the newer medications require more explanation than in the past, and the best way to take advantage of glucose testing devices has changed. This continuing education course gives the pharmacist a solid knowledge base to enlighten the patients on these new therapies. Special emphasis will be placed on methods to help the patient control post-prandial glucose thru the use of glucose monitoring.
Objectives:
At the completion of this program, the pharmacist should be able to:
- Distinguish between the mechanism of action for oral secretagogues, biguanides, thiazolidinediones, and alpha-glucosidase inhibitors.
- Discuss the contribution of postprandial glucose concentrations to overall glycemic control.
- Discuss the advantages and disadvantages of inhaled insulin.
- Assess the clinical utility of recently developed injectable and oral antihyperglycemic therapies for treating diabetes.
Target Audience:
Pharmacists
Faculty Disclosure:
AAF-MED and RxSchool have a “Full and Fair Disclosure Policy” that requires course faculty to communicate any real or apparent commercial affiliations related to the content of their presentations/materials. Mr. Joffe has no conflicts of interest to disclose.
Fee:
This is a free course
|
Macromedia Flash